| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/25/1990 | WO1990000617A1 Antibodies specific towards gp 48 |
| 01/25/1990 | WO1990000616A1 Recombinomas |
| 01/25/1990 | WO1990000610A1 New expression vectors |
| 01/25/1990 | WO1990000609A1 Cellulose binding fusion proteins |
| 01/25/1990 | WO1990000606A1 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 01/25/1990 | WO1990000605A1 Methods and means for controlling the stability of proteins |
| 01/25/1990 | WO1990000601A2 Novel glucose isomerase enzymes and their use |
| 01/25/1990 | WO1990000597A1 Post-transfusion, non-a, non-b hepatitis virus and antigens |
| 01/25/1990 | WO1990000594A2 Recombinant mycobacterial expression vehicles and uses therefor |
| 01/25/1990 | WO1990000569A1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
| 01/25/1990 | WO1990000567A1 A migration stimulating factor |
| 01/25/1990 | WO1990000565A1 Interleukin ii analogs |
| 01/25/1990 | WO1990000563A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
| 01/25/1990 | WO1990000558A1 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
| 01/25/1990 | WO1990000405A1 Immunoconjugates for cancer diagnosis and therapy |
| 01/25/1990 | WO1990000403A1 Genetically engineered coccidiosis vaccine |
| 01/25/1990 | WO1990000400A1 Tumor necrosis enhancing factor and methods of preparation and use |
| 01/25/1990 | WO1990000398A1 Method of preparing surface membrane antigens from human carcinoma cells |
| 01/25/1990 | DE3923583A1 Verwendung von pam-enzym in festphasen-peptidsynthesen Use of pam-enzyme in solid-phase peptide syntheses |
| 01/24/1990 | EP0352250A2 Bordetella pertussis vaccine |
| 01/24/1990 | EP0352228A2 Novel proteins |
| 01/24/1990 | EP0352227A2 Modified proteins |
| 01/24/1990 | EP0352119A2 Vampire bat salivary plasminogen activators |
| 01/24/1990 | EP0352092A2 Novel antibiotics R106 |
| 01/24/1990 | EP0352090A2 Method for preparation of nephritogenoside |
| 01/24/1990 | EP0352089A2 A modified human PSTI |
| 01/24/1990 | EP0352073A1 Vectors, cells transformed thereby, and their use in producing heterologous polypeptides |
| 01/24/1990 | EP0352060A2 Expression plasmid and use thereof |
| 01/24/1990 | EP0351944A1 Monoclonal antibodies to immunogenic human interleukin-3 peptide |
| 01/24/1990 | EP0351921A2 Modified beta adrenergic receptor |
| 01/24/1990 | EP0351826A2 DNA encoding an anticoagulant polypeptide |
| 01/24/1990 | EP0351789A2 Improved monoclonal antibodies reactive with cachectin |
| 01/24/1990 | EP0351731A2 Monoclonal antibodies capable of recognizing gangliosides GQ1b and GT1a |
| 01/24/1990 | EP0351586A1 Plasmids containing a chicken beta-actin promoter and a human factor VIII:C gene, transformants and processes for preparing human factor VIII:C |
| 01/24/1990 | EP0351427A1 Bacillus cells |
| 01/23/1990 | US4895932 Method for determining cardiodilatin and fragments thereof and antibodies useful in determination of cardiodilatin and its fragments |
| 01/23/1990 | US4895800 Biosynthesis, pichia, genetic engineering |
| 01/23/1990 | US4895796 Natural killer cells, two different labeled reagents |
| 01/23/1990 | CA1264687A1 Recombinant plasmid and microbial strain transformed by said plasmid |
| 01/17/1990 | EP0351244A2 Antibodies and methods for immunochemical assay using them |
| 01/17/1990 | EP0351045A2 Monoclonal antibody NUH2 capable of inactivating motility of sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
| 01/17/1990 | EP0350810A2 Process for obtaining, isolating and purifying epidermin |
| 01/17/1990 | EP0350715A1 Recombinant treponema hyodysenteriae antigen and uses therefor |
| 01/17/1990 | EP0350690A2 Neutralisation of the in vitro and in vivo toxic properties of TNF-alpha by monoclonal antibodies and by fragments derived therefrom |
| 01/17/1990 | EP0350506A1 Pulmonary surfactant protein and related polypeptide |
| 01/17/1990 | CN1038837A Recombinant coccidiosis vaccines |
| 01/16/1990 | US4894443 Polypeptides, antibodies |
| 01/16/1990 | US4894442 Monoclonal antibodies that bind to alpha-acid glycoprotein |
| 01/16/1990 | US4894440 Method of isolating megakaryocyte stimulatory factor |
| 01/16/1990 | US4894436 Genetic engineering, polypeptides |
| 01/16/1990 | US4894333 Bovine interleukin-1α |
| 01/16/1990 | US4894332 Diagnosis, antibodies |
| 01/16/1990 | US4894330 Purification of recombinant beta-interferon incorporating RP-HPLC |
| 01/16/1990 | US4894327 Anti-human mesothelial cell monoclonal antibody |
| 01/16/1990 | US4894226 Spacers, crosslinking |
| 01/16/1990 | US4894161 Flocculation, cultures |
| 01/11/1990 | WO1990000204A1 Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses |
| 01/11/1990 | WO1990000200A1 Thermal release of recombinant protein into culture media |
| 01/11/1990 | WO1990000194A1 Suppression of cell proliferation by decorin |
| 01/11/1990 | WO1990000179A2 Novel proteins, dna coding for said proteins, and their use |
| 01/11/1990 | WO1990000178A1 Platelet blocking peptides |
| 01/11/1990 | WO1990000062A1 Antibody recognition of fragments from cytomegalovirus |
| 01/11/1990 | WO1989002465A3 Polypeptide production |
| 01/10/1990 | EP0350341A1 Cloning and expression vectors in an Aktinomyces strain,method of transformation of this strain,obtained strain and preparation of proteins |
| 01/10/1990 | EP0350230A2 Immunoconjugates for cancer diagnosis and therapy |
| 01/10/1990 | EP0350218A2 Monoclonal antibodies recognizing gamma atrial natriuretic polypeptide, hybridomas producing such antibodies, and their preparation and use |
| 01/10/1990 | EP0349851A2 N-oma cell lines as means for immortalizing substance producing cells of any animal species |
| 01/10/1990 | EP0349769A1 Genetically engineered bacillus sphaerocus producing larvicidal toxin from bacillus thuringiensis var. israelensis |
| 01/10/1990 | EP0349594A1 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
| 01/10/1990 | EP0216846B1 Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| 01/10/1990 | EP0146572B1 Method for controlling the expression of cloned genes |
| 01/10/1990 | CN1038668A Expression of hepatitis b and pres 2 proteins in methylotrophic yeasts |
| 01/09/1990 | US4892935 Anti-human pulmonary carcinoma monoclonal antibody |
| 01/09/1990 | US4892934 Process for preparing hybridoma cells which produce tumor-specific monoclonal antibodies |
| 01/09/1990 | US4892827 Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
| 01/09/1990 | US4892824 Fast track method for producing monoclonal bi-specific immunoglobulins |
| 01/09/1990 | US4892820 Preparation of dipeptides, aspartame, alkyl phosphate |
| 01/09/1990 | CA1264294A1 METHOD FOR PRODUCING HUMAN LEUKOCYTE INTERFERON .alpha.-2 |
| 01/09/1990 | CA1264292A1 Purified antigen from non-a, non-b hepatitis causing factor |
| 01/08/1990 | EP0312540A4 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins. |
| 01/03/1990 | EP0349480A1 Supression of cell proliferation by decorin |
| 01/03/1990 | EP0349435A1 Method for the preparation of a protein by yeast using an inductible system, vectors and corresponding transformed strains |
| 01/03/1990 | EP0349354A1 Peptides PF10 to PF19 from a retro virus HIV, method for the synthesis of these peptides and their use, particularly in diagnostics |
| 01/03/1990 | EP0349353A1 DNA sequences comprising the bacillus subtilis functional part of locus sacU and sacUh, vectors containing these sequences and their use in processes for the production of proteins |
| 01/03/1990 | EP0349342A2 Polypeptides with cell-spreading activity |
| 01/03/1990 | EP0349338A2 ENOD2 gene regulatory region |
| 01/03/1990 | EP0349258A2 Method of determining the differentiation of a human T-cell |
| 01/03/1990 | EP0349257A1 Method of diagnosing in vitro down's syndrome |
| 01/03/1990 | EP0349127A1 Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells |
| 01/03/1990 | EP0349071A1 Coccidiosis vaccine |
| 01/03/1990 | EP0349048A2 Osteogenic growth factors derived from regenerating bone marrow |
| 01/03/1990 | EP0348973A2 Anti-human pulmonary adenocarcinome monoclonal antibody |
| 01/03/1990 | EP0348780A2 Process for producing proteins |
| 01/03/1990 | EP0348725A2 Species-specific epitode of chlamydia trachomatis and antibodies that recognize the same |
| 01/03/1990 | EP0348442A1 Altered antibody |
| 01/03/1990 | EP0348413A1 Method for the generation of antigen-specific t cell lines and therapeutic use thereof |
| 01/03/1990 | EP0348399A1 Sorbin and peptide derivatives which increase aborption by the mucous membranes. |
| 01/03/1990 | EP0211835B1 Pharmaceutical compositions of microbially produced interleukin-2 |
| 01/02/1990 | US4891316 Genetic engineering |
| 01/02/1990 | US4891310 Method of controlling culture |